Assess retrospectively the interest of performing viscosupplementation using imaging guidance in patients suffering from ankle osteoarthritis

Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily Practice

Article specifications

This Clinical trial was published in 2016 in Clin Med Insights Arthritis Musculoskelet Disord. (IF2015: 3.25) by French ophthalmologists. The objective of this survey was to assess retrospectively the interest of performing viscosupplementation using imaging guidance in patients suffering from ankle osteoarthritis (OA). Fifty patients suffering from ankle OA and treated, in daily clinical practice, with a single intra-articular injection of a novel viscosupplement made of a combination of a non-animal cross-linked hyaluronan and mannitol, HANOX M-XL, were included in the survey. The injection procedure (imaging or landmark guidance), demographic data, patient’s self-evaluation of pain, satisfaction, treatment efficacy, and tolerability were collected. Predictive factors of both efficacy and patient’s satisfaction were investigated.

 

Results

In summary, the present survey showed that imaging guidance is useful to optimize the results of viscosupplementation in ankle OA. Five months after a single injection of HANOX M-XL in the target ankle of patients with talocrural OA, three patients out of four remained satisfied with the treatment provided the viscosupplement was injected under imaging control to ensure the accurate IA injection.